Screening Children for Early-Stage Type 1 Diabetes
JAMA · 16.06.2026 · 335 (23) · 2046
DOI: 10.1001/jama.2026.6085 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JAMA, erschienen am 16.06.2026. Verfasst von Christiane Winkler und 35 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany. Hauptthemen laut MEDLINE: Autoantibodies, Diabetes Mellitus, Type 1, Mass Screening, Asymptomatic Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus, Kinderkrankenpflege
Abstract (Originalsprache)
Importance Detecting type 1 diabetes in presymptomatic stages is essential for therapies aimed at delaying clinical onset.
Objective
To estimate early-stage (stage 1 or 2) type 1 diabetes prevalence and disease progression to clinical (stage 3) type 1 diabetes in children in a population-based screening study. Design, Setting, and Participants From February 2015 to July 2025, children living in Bavaria, Germany, were screened for early-stage type 1 diabetes. Screening was conducted by 716 primary care pediatricians. Screening was performed once in children aged 1.75 to 5.99 years until March 2019 and was subsequently expanded to include up to 2 screenings in children aged 1.75 to 10.99 years. Families of children with early-stage disease were offered diabetes education, metabolic staging, and longitudinal monitoring in 18 specialized diabetes centers. Exposures Measurement of islet autoantibodies. Main Outcomes and Measures The primary outcome was early-stage type 1 diabetes, defined as 2 or more autoantibodies against insulin, glutamic acid decarboxylase, islet antigen-2, or zinc transporter 8 confirmed in consecutive blood samples, with categorization into stages 1 (normoglycemia) and 2 (dysglycemia) and progression to clinical (stage 3) diabetes.
Results
Among 220 476 enrolled children (median [IQR] age, 3.1 [2.2-5.0] years; 106 952 [48.7%] females), 590 had presymptomatic early-stage type 1 diabetes at first screening (adjusted population frequency, 0.3% [95% CI, 0.28%-0.32%]) with prevalences of 0.23% for stage 1 and 0.06% for stage 2 type 1 diabetes. Repeat screening in 11 726 children after a median of 3.3 years identified 29 additional cases. During a median follow-up of 5.7 years, 212 children with an early-stage diagnosis at first screening, 5 with a diagnosis at rescreening, and 43 without an early-stage diagnosis developed clinical (stage 3) diabetes. Five-year progression from early-stage to clinical diabetes was 36.2% (95% CI, 31.2%-40.8%; annualized rate, 9.6%), and not significantly different between children with and without a first-degree family history ( P = .54). Conclusions and Relevance General population screening of children identified early-stage type 1 diabetes and similar progression rates to clinical diabetes between children with and without a first-degree family history. These findings inform disease-modifying therapy trials and suggest that screening can be considered beyond genetically selected populations. Trial Registration ClinicalTrials.gov Identifier: NCT04039945
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.
- German Center for Diabetes Research (DZD), Munich, Germany.
- Kinder- und Jugendärzte Wendelstein, Wendelstein, Germany.
- Nuremberg Hospital South, Nuremberg, Germany.
- Pediatric Clinic of the Bayreuth Hospital, Bayreuth, Germany.
- RoMed Hospital, Rosenheim, Germany.
Zitieren
APA
Winkler, C., Friedl, N., Abt, R., Ackermann, K., Bently, J., Braig, S., Brämswig, S., Dunstheimer, D., Ermer, U., Ewald, D., Gerstl, E. M., Hammersen, J., Haupt, F., Hergl, M., Hubmann, M., Hummel, S., Jochem, B., Knopff, A., Lange, K., …, & Ziegler, A. G. (2026). Screening Children for Early-Stage Type 1 Diabetes. JAMA, 335(23), 2046. https://doi.org/10.1001/jama.2026.6085
Vancouver
Winkler C, Friedl N, Abt R, Ackermann K, Bently J, Braig S, et al. Screening Children for Early-Stage Type 1 Diabetes. JAMA. 2026;335(23):2046. doi:10.1001/jama.2026.6085
BibTeX
@article{Winkler2026,
author = {Winkler, Christiane and Friedl, Nadine and Abt, Renate and Ackermann, Kathrin and Bently, Julia and Braig, Sonja and Brämswig, Susanne and Dunstheimer, Desiree and Ermer, Uwe and Ewald, Dominik and Gerstl, Eva-Maria and Hammersen, Johanna and Haupt, Florian and Hergl, Maja and Hubmann, Michael and Hummel, Sandra and Jochem, Benedikt and Knopff, Annette and Lange, Karin and Lwowsky, Dominik and Nellen-Hellmuth, Nicole and Prey, Birgit and Rettner, Daniela and Schill, Sarah and Schmidt, Silke and Scholz, Marlon and Sindichakis, Marina and Stock, Joanna and Stricker, Dominik and Völkl, Thomas M K and Warncke, Katharina and Weber, Leonie and Weiss, Andreas and Bonifacio, Ezio and Achenbach, Peter and Ziegler, Anette-Gabriele},
title = {Screening Children for Early-Stage Type 1 Diabetes},
journal = {JAMA},
year = {2026},
volume = {335},
number = {23},
pages = {2046},
doi = {10.1001/jama.2026.6085}
}
EUVIMED